1 Min Read
March 23 (Reuters) - HTG Molecular Diagnostics Inc
* HTG Molecular Diagnostics reports fourth quarter and full year 2016 results
* Q4 revenue $1.5 million versus $1.2 million
* Q4 loss per share $0.76 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.